Global Generative AI (GenAI) in Digital Health Market Size is valued at USD 1.6 Bn in 2024 and is predicted to reach USD 33.7 Bn by the year 2034 at a 36.5% CAGR during the forecast period for 2025-2034.
Generative AI (GenAI) is revolutionizing digital health by enhancing diagnostics, drug discovery, personalized medicine, and patient care. Key applications include improving medical imaging, generating synthetic data, supporting clinical decisions, and powering health chatbots. GenAI generates contextually relevant and realistic data using complex algorithms, enabling quicker and more intelligent medical code searches. The advantages of GenAI in digital health are numerous and include improved patient outcomes through precision medicine, faster clinical workflows, and increased accuracy in medical imaging interpretation.
Optimizing resource allocation and decision-making in healthcare systems has become possible through GenAI's rapid analysis of large datasets and ability to produce actionable insights. The growing availability of huge healthcare datasets, the expanding use of AI in healthcare, and the demand for more accurate and efficient decision-making tools are some of the drivers propelling GenAI in the digital health industry.
Furthermore, a number of healthcare applications are made possible by the quick development of deep learning models, such as GPT and NLP tools. These consist of conversational AI for patient support, automated reporting, and medical imaging analysis. The healthcare industry is adopting generative AI solutions as a result of these technological advancements. However, GenAI in the digital health market expansion is probably going to be hampered by issues with data security and privacy, legal obstacles, the high cost of developing, implementing, and maintaining generative AI systems, and moral dilemmas surrounding the application of AI in healthcare.
Some Major Key Players In The Generative AI (GenAI) in Digital Health Market:
The Generative AI (GenAI) in Digital Health market is segmented based on deployment, technology, application, and end-user. The market is segmented by deployment into Cloud-based, On-premises, Hybrid, and Edge Computing solutions. Based on technology, it is categorized into Natural Language Processing (NLP), Machine Learning (ML), Predictive Analytics, and Deep Learning (DL). By application, the market includes Drug Discovery and Development, Virtual Health Assistants, Personalized Medicine, and Diagnostic Tools and Imaging. In terms of end-users, the market comprises Hospitals and Clinics, Research Institutes, Pharmaceutical Companies, and Diagnostic Centers.
The Machine Learning (ML) category is expected to hold a major global market share in 2024 due to machine learning's adaptability in healthcare applications, which include personalized treatment and predictive analytics. In order to improve diagnosis and treatment planning, machine learning algorithms are essential for identifying patterns in complicated medical data. It is anticipated that the growing need for data-driven insights in healthcare applications will continue to encourage the adoption of machine learning.
Throughout the projection period, the Diagnostic Tools and Imaging category is anticipated to hold the greatest revenue share among the application categories. The need for sophisticated diagnostic tools and imaging is being driven by the rising existance of chronic illnesses worldwide. For instance, the World Heart Federation estimates that 20.5 million people died from cardiovascular disorders in 2021, affecting over 500 million people globally. As a result, Generative AI (GenAI) in Digital Health has grown to be crucial for the early identification and tracking of various illnesses, greatly boosting market expansion. Furthermore, enhancing patient outcomes requires early diagnosis, and AI models help spot possible health problems before they manifest symptoms.
The North American Generative AI (GenAI) in the Digital Health market is expected to register the highest market share in revenue in the near future because of the existence of a sophisticated healthcare system and significant investments in artificial intelligence. The telemedicine, health IT, and electronic health record (EHR) industries are growing quickly, which makes it perfect for incorporating generative AI into digital health processes. The utilization of AI tools for data analysis, patient interaction, and clinical decision support is made easier by this digital environment. As a result, it is projected that the previously mentioned drivers will drive market expansion throughout the forecast period. In addition, Asia Pacific is projected to grow rapidly in the global Generative AI (GenAI) in the Digital Health market. The need for effective data analysis and decision support tools in the healthcare industry, the growing need for personalized medication, and technological improvements in healthcare are some of the common causes propelling the adoption of GenAI in digital health in the Asia Pacific.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 1.6 Bn |
|
Revenue Forecast In 2034 |
USD 33.7 Bn |
|
Growth Rate CAGR |
CAGR of 36.5% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Deployment, Technology, Application, And End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Siemens Healthineers, Philips Healthcare, Intel Corporation, Tempus Labs, PathAI, Aidoc Medical, Zebra Medical Vision, NVIDIA Corporation, Microsoft Corporation, Google (Alphabet Inc.) - Google Health, IBM Watson Health, Butterfly Network, and Tempus. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Generative AI (GenAI) in Digital Health Market Snapshot
Chapter 4. Global Generative AI (GenAI) in Digital Health Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Generative AI (GenAI) in Digital Health Industry Trends
4.10. Global Generative AI (GenAI) in Digital Health Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Generative AI (GenAI) in Digital Health Market Segmentation 1: By Deployment, Estimates & Trend Analysis
5.1. Market Share by Deployment, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Deployment:
5.2.1. Cloud-based Solutions
5.2.2. On-premises Solutions
5.2.3. Hybrid Solutions
5.2.4. Edge Computing Applications
Chapter 6. Generative AI (GenAI) in Digital Health Market Segmentation 2: By Technology, Estimates & Trend Analysis
6.1. Market Share by Technology, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology:
6.2.1. Natural Language Processing (NLP)
6.2.2. Machine Learning (ML)
6.2.3. Deep Learning (DL)
6.2.4. Predictive Analytics
Chapter 7. Generative AI (GenAI) in Digital Health Market Segmentation 3: By Application, Estimates & Trend Analysis
7.1. Market Share by Application, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
7.2.1. Drug Discovery and Development
7.2.2. Personalized Medicine
7.2.3. Diagnostic Tools and Imaging
7.2.4. Virtual Health Assistants
Chapter 8. Generative AI (GenAI) in Digital Health Market Segmentation 4: By End User, Estimates & Trend Analysis
8.1. Market Share by End User, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:
8.2.1. Hospitals and Clinics
8.2.2. Pharmaceutical Companies
8.2.3. Research Institutes
8.2.4. Diagnostic Centers
Chapter 9. Generative AI (GenAI) in Digital Health Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Generative AI (GenAI) in Digital Health Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by Deployment, 2021-2034
9.2.3. North America Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.2.4. North America Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.5. North America Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.3. Europe
9.3.1. Europe Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by Deployment, 2021-2034
9.3.3. Europe Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.3.4. Europe Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.5. Europe Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by Deployment, 2021-2034
9.4.3. Asia Pacific Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.4.4. Asia Pacific Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.5. Asia Pacific Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.5. Latin America
9.5.1. Latin America Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by Deployment, 2021-2034
9.5.3. Latin America Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.5.4. Latin America Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.5. Latin America Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by Deployment, 2021-2034
9.6.3. Middle East & Africa Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.6.4. Middle East & Africa Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.6.5. Middle East & Africa Generative AI (GenAI) in Digital Health Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. F. IBM Watson Health
10.2.1.1. Business Overview
10.2.1.2. Key Deployment/Service Overview
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. NVIDIA Corporation
10.2.3. Siemens Healthineers
10.2.4. Philips Healthcare
10.2.5. Intel Corporation
10.2.6. Microsoft Corporation
10.2.7. Google (Alphabet Inc.) - Google Health
10.2.8. Aidoc Medical
10.2.9. Butterfly Network
10.2.10. Tempus Labs
10.2.11. PathAI
10.2.12. Zebra Medical Vision
10.2.13. Tempus
Segmentation of Generative AI (GenAI) in Digital Health Market-
Generative AI (GenAI) in Digital Health Market By Deployment-
Generative AI (GenAI) in Digital Health Market By Technology-
Generative AI (GenAI) in Digital Health Market By Application-
Generative AI (GenAI) in Digital Health Market By End-User-
Generative AI (GenAI) in Digital Health Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
